Beijing Aosaikang Pharmaceutical Co., Ltd. (SHE:002755)
19.57
+0.10 (0.51%)
Nov 3, 2025, 2:45 PM CST
SHE:002755 Revenue
Beijing Aosaikang Pharmaceutical had revenue of 426.48M CNY in the quarter ending September 30, 2025, a decrease of -7.67%. This brings the company's revenue in the last twelve months to 1.83B, up 6.96% year-over-year. In the year 2024, Beijing Aosaikang Pharmaceutical had annual revenue of 1.78B with 23.15% growth.
Revenue (ttm)
1.83B
Revenue Growth
+6.96%
P/S Ratio
9.89
Revenue / Employee
1.85M
Employees
988
Market Cap
18.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.78B | 334.18M | 23.15% |
| Dec 31, 2023 | 1.44B | -429.11M | -22.92% |
| Jan 1, 2023 | 1.87B | -1.23B | -39.72% |
| Jan 1, 2022 | 3.11B | -676.02M | -17.87% |
| Dec 31, 2020 | 3.78B | -735.94M | -16.29% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Huadong Medicine | 43.09B |
| WuXi AppTec | 43.07B |
| Yunnan Baiyao Group Co.,Ltd | 40.77B |
| Shanghai Fosun Pharmaceutical (Group) | 39.55B |
| Shenzhen Mindray Bio-Medical Electronics | 33.07B |
| Jiangsu Hengrui Medicine | 30.98B |
| Zhejiang NHU Company | 22.47B |
| Aier Eye Hospital Group | 22.17B |